Rodec Pharma Limited

Rodec Pharma Limited - pharma in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U24233UP1997PLC239832 Incorporated 18 November 1997 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹108.15 Cr
▲ 20.00% YoY
EBITDA · FY 2025
*****
▲ 61.00% YoY
Net profit · FY 2025
*****
▲ 63.00% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹22.58 Cr
Issued & subscribed
Open charges
₹142.48 Cr
Satisfied ₹8.51 Cr
Company age
29 yrs
Est. 1997
Last financials
Mar 2024
Balance sheet date

About Rodec Pharma Limited

Data last updated: 22 December 2025

Rodec Pharma Limited is a public limited company based in New Delhi, Delhi, India. It specialises in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 18 November 1997, the company has been in operation for over 29 years.

Registered with ROC Delhi under CIN U24233DL1997PTC090729.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹22.58 Cr. Formerly known as Rodec Pharmaceuticals Private Limited. It is led by directors including Chhaya Gupta and Utkarsh Gupta.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: F – 46 Pankaj Central Market I.P Extension Patparganj, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹108.15 Cr, a growth of 20% compared to the previous year.

As per MCA filings, the company has open charges of ₹142.48 Cr and satisfied charges of ₹8.51 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rodec.in.

Company Details of Rodec Pharma Limited
CIN U24233UP1997PLC239832
Registration Number 090729
Incorporation Date 18 November 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Chhaya Gupta Director Utkarsh Gupta Director Mukesh Kumar Gupta Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
  • Registered Address
    F – 46 Pankaj Central Market I.P Extension Patparganj, New Delhi, Delhi, India – 110092
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare
Company report
Rodec Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Rodec Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Rodec Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Rodec Pharma Limited

Rodec Pharma Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24233UP1997PLC239832, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24233UP1997PLC239832 Current
U24233DL1997PTC090729 Previous
U24233DL1997PLC090729 Previous

Business Activity of Rodec Pharma Limited

Rodec Pharma Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including veterinary activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M8 Veterinary activities *********

Board of Directors of Rodec Pharma Limited

Rodec Pharma Limited is currently managed by 8 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Chhaya Gupta
Also directs: Rodec Healthcare Private Limited
Director 18 Nov 1997 28 Years 7 Months Current
Utkarsh Gupta Director 24 Mar 2023 3 Years 3 Months Current
Mukesh Kumar Gupta
Also directs: Rodec Healthcare Private Limited, M2g Health Solutions Private Limited
Director 01 Dec 2000 25 Years 7 Months Current
Achal Kapoor
Also directs: Davangere Sugar Company Limited, Kairosoft Ai Solutions Limited, Ems Limited and 5 more
Additional Director 23 Aug 2025 0 Years 10 Months Current
Nikita Sinha
Also directs: Kotia Enterprises Limited, Kabra Drugs Limited, Vinod Texworld Limited and 2 more
Additional Director 23 Aug 2025 0 Years 10 Months Current
Preeti
Also directs: Vintage Coffee And Beverages Limited, Rajnish Wellness Limited, Consecutive Commodities Limited and 2 more
Additional Director 23 Aug 2025 0 Years 10 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Rodec Pharma Limited FY 2024 filings available

Rodec Pharma Limited reported revenue of ₹108.15 Cr (up 20% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹108.15 Cr ▲ 20%
Profit
***** ▲ 63%
EBITDA
***** ▲ 61%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Rodec Pharma Limited

Open charges
₹142.48 Cr
Satisfied charges
₹8.51 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹141.97 Cr
Axis Bank Limited₹0.52 Cr
Latest charge details
DateLenderAmountStatus
22 Aug 2024 Hdfc Bank Limited ₹30 Lakh Open
22 Jun 2023 Hdfc Bank Limited ₹16.6 Lakh Open
29 Dec 2022 Hdfc Bank Limited ₹1 Cr Open
28 Jun 2022 Hdfc Bank Limited ₹140.5 Cr Open
19 Nov 2020 Axis Bank Limited ₹51.72 Lakh Open

Total charge records: 10 View all charges

Employees and EPFO Compliance at Rodec Pharma Limited

View historical data on people associated with Rodec Pharma Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Rodec Pharma Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Rodec Pharma Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Rodec Pharma Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Rodec Pharma Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Rodec Pharma Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Rodec Pharma Limited

MSME Payment Delays by Rodec Pharma Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Rodec Pharma Limited

Subsidiaries & Group Companies of Rodec Pharma Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Rodec Pharma Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Rodec Pharma Limited

MCA Filings & Documents of Rodec Pharma Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Rodec Pharma Limited

Directors
22 Nov 2025
Shivam Gupta was appointed as a Cfo on 22 Nov 2025 & has been associated with this company since 7 months 17 days.
Directors
07 Sep 2025
Keshav Kumar Sharma was appointed as a Company Secretary on 07 Sep 2025 & has been associated with this company since 10 months 1 day.
Directors
23 Aug 2025
Achal Kapoor was appointed as a Additional Director on 23 Aug 2025 & has been associated with this company since 10 months 16 days.
Directors
23 Aug 2025
Nikita Sinha was appointed as a Additional Director on 23 Aug 2025 & has been associated with this company since 10 months 16 days.
Directors
23 Aug 2025
Preeti was appointed as a Additional Director on 23 Aug 2025 & has been associated with this company since 10 months 16 days.
Charges
06 May 2025
A charge with Hdfc Bank Limited of Rs. 140.50 Cr registered on 28 Jun 2022 with Charge ID 100602715 was modified on 06 May 2025.

Frequently Asked Questions about Rodec Pharma Limited

Rodec Pharma Limited is an active public limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 18 November 1997 (29+ years old) and is registered under CIN U24233UP1997PLC239832.

Rodec Pharma Limited reported revenue of ₹108.15 Cr for FY 2025 (up 20.00% YoY).

The current directors of Rodec Pharma Limited are:

The primary industry of Rodec Pharma Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare. The company is currently active in this sector.

Rodec Pharma Limited can be reached at the registered office: F – 46 Pankaj Central Market I.P Extension Patparganj, New Delhi, Delhi, India – 110092, or through the website rodec.in.

The authorised capital is ₹25 Cr, and the paid-up capital is ₹22.58 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available